Sunday, September 13, 2026

Celltrion Moves CT-G32 Into Final Preclinical Stage as Global Obesity Trial Preparation Accelerates

Celltrion advances CT-G32, a next-gen obesity treatment, targeting multiple pathways to enhance weight loss while preserving muscle mass.

Japan Secures Trade Deal: What Does It Mean for Pharmaceuticals and Semiconductors?

U.S. and Japan's trade negotiations reveal discrepancies in tariff agreements, especially for pharmaceuticals and semiconductors, raising concerns.

Weight-Loss Drugs Could Cut Airline Fuel Bills by $580 Million—An Unexpected Win for U.S. Carriers

The obesity treatment market is growing, helping U.S. airlines save on fuel costs due to decreased passenger weight.

Trump Breaks the Deal with South Korea: Why a Jump From 15% to 25% Tariffs Has Other Partners Nervous

PoliticsTrump Breaks the Deal with South Korea: Why a Jump From 15% to 25% Tariffs Has Other Partners Nervous

The Financial Times (FT) reported on Tuesday that President Donald Trump’s sudden increase in tariffs on South Korea marks the first time he has raised duties on a country with which he had already completed tariff negotiations. This move has put other nations that have finalized trade deals on edge.

Last July, Trump and South Korea reached an agreement to lower tariffs on South Korean goods to 15% in exchange for a 350 billion USD investment from Seoul.

This deal was finalized during Trump’s October 2025 visit to South Korea.

However, Trump abruptly announced that he would raise South Korea’s tariffs from the agreed-upon 15% to 25%.

As a result, South Korea became the first country to face additional tariff hikes despite having completed negotiations. The FT noted that this development has caused anxiety among other nations that have already concluded tariff agreements.

The FT also pointed out that Trump has frequently expressed frustration with some countries for not implementing agreements swiftly enough.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles